Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
03/2014
03/13/2014US20140073622 Imidazole carbonyl compound
03/13/2014US20140073620 Vegfr3 inhibitors
03/13/2014US20140073579 SMAC Mimetic
03/13/2014DE102012215896A1 Moxonidinsynthese mit Hilfe organischer Basen Moxonidinsynthese using organic bases
03/12/2014EP2706057A1 Bis(imidazolyl)compounds and radionuclide complexes
03/12/2014EP2705033A1 Isoindolinone derivatives
03/12/2014EP2704574A1 Cyclohexene benzotriazole derivatives
03/12/2014CN103635464A Polyphenylene host compounds
03/12/2014CN103635191A Small molecule RNASE inhibitors and methods of use
03/12/2014CN103626752A Dihydropyrimidine compounds and application of same in drugs
03/12/2014CN103626742A Bi-aryl meta-pyrimidine inhibitors of kinases
03/12/2014CN103626741A Heterocyclic aminopyrimidine compound with adenosine receptor antagonist activity
03/12/2014CN103626713A Aza (oxa)-cyclopentane-2- ketone (thione) compounds, medicine compositions thereof, preparation method and applications
03/12/2014CN102532107B 4-substituted aniline-7-substituted alcoxylhomopiperazine-quinazoline derivatives, and preparation method and application thereof
03/12/2014CN102516153B 5-fluoroindole-2-one-3-carbamide compounds, preparation method thereof and application thereof
03/12/2014CN102395580B Crystalline polymorphic form 631
03/12/2014CN102395579B Hepatitis c virus inhibitors
03/12/2014CN101842368B Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
03/12/2014CN101720318B Quinazolin-oxime derivatives as Hsp90 inhibitors
03/12/2014CN101679350B Quinoline derivatives for treatment of inflammatory diseases
03/12/2014CN101558055B Spiro substituted compounds as angiogenesis inhibitors
03/11/2014US8669274 Metalloenzyme inhibitor compounds
03/11/2014US8669234 Antiviral compounds
03/11/2014CA2784180C Seven-membered ring compound and pharmaceutical use therefor
03/06/2014WO2014036022A1 Quinazolinone compounds and derivatives thereof
03/06/2014WO2014035872A1 Tricyclic alkynes that interact with glucokinase regulatory protein
03/06/2014WO2014035860A1 Inhibitors of beta-secretase
03/06/2014WO2014034868A1 Method for producing biaryl compound
03/06/2014WO2014034584A1 Organic electroluminescent element, illuminator, and display device
03/06/2014WO2014034535A1 Light emitting material, compound and organic light emitting element using light emitting material
03/06/2014WO2014033758A1 4-tert-butyl-n-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2(2-pyrimidinyl)-pyrimidine-4-yl)-benzen esulfonamide sodium
03/06/2014WO2014033448A1 Pyrazole derivatives as p38 map inhibitors
03/06/2014WO2014033447A2 Kinase inhibitors
03/06/2014WO2014033244A2 Substituted mesoionic imine compounds for combating animal pests
03/06/2014WO2014032801A1 Fluoromethyl-substituted pyrrole carboxamides
03/06/2014WO2014008838A4 Bis-indolylacetic acid derivative attached with aryl substituted methyl, and preparation method and use thereof
03/06/2014WO2013063468A8 Amino acid derivates functionalized on the n- terminal capable of forming drug incapsulating microspheres
03/06/2014US20140066632 Copper-catalysed ligation of azides and acetylenes
03/06/2014US20140066623 Ribosome Structure and Protein Synthesis Inhibitors
03/06/2014US20140066619 Process for the preparation of 1 - (2-methyl-4- (2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl) benzylcarbamoyl) - l - proline - n, n-dimethylamide
03/06/2014US20140066476 Modulators of cellular adhesion
03/06/2014US20140066466 Necroptosis Inhibitors and Methods of Use Therefor
03/06/2014US20140066460 Synthesis and novel salt forms of (r)-5-((e)-2-pyrrolidin-3ylvinyl)pyrimidine
03/06/2014US20140066455 Novel compounds
03/06/2014US20140066448 Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
03/06/2014US20140066443 Aminomethyl biaryl benzotriazole derivatives
03/06/2014US20140066432 Substituted Benzoazepines As Toll-Like Receptor Modulators
03/06/2014US20140066426 Fluoromethyl-substituted pyrrole carboxamides
03/06/2014US20140066425 Androgen receptor antagonists and uses thereof
03/06/2014US20140066422 Phenoxy-substituted pyrimidines as opioid receptor modulators
03/06/2014US20140066404 Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same
03/06/2014US20140066369 Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
03/06/2014US20140065095 Novel inhibitors
03/06/2014DE102012215520A1 Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an einem oder mehreren Pyridazinderivaten und Verwendung von einem oder mehreren Pyridazin-derivaten zur Herstellung kosmetischer Zubereitungen zur Bräunung der Haut Cosmetic or dermatological preparations with a content of one or more of pyridazine derivatives, and use of one or more pyridazine derivatives for the preparation of cosmetic compositions for skin tanning
03/05/2014EP2702987A1 Phosphodiesterase type III (PDE III) inhibitors or Ca2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
03/05/2014EP2702986A1 Phosphodiesterase type III (PDE III) inhibitors or CA2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
03/05/2014EP2702056A1 Derivatives of n- [(1h-pyrazol-1-yl) aryl]- 1h - indole or 1h - indazole - 3 - carboxamide, their preparation and their use as p2y12 antagonists
03/05/2014EP2702055A1 Pyrazolyl-pyrimidine derivatives as kinase inhibitors
03/05/2014EP2702051A1 Ethynyl derivatives as positive allosteric modulators of the mglur5
03/05/2014EP2702050A1 Pyrazolidin-3-one derivatives
03/05/2014EP2702043A1 Inhibitors of inducible form of 6-phosphofructose-2-kinase
03/05/2014EP2702042A1 Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators
03/05/2014CN103620808A Organic electroluminescent element
03/05/2014CN103619841A Heteroaryl compounds and methods of use thereof
03/05/2014CN103619835A Novel pyrimidine derivatives
03/05/2014CN103619834A Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H-indazole-3-carboxamide, their preparation and their use as P2Y12 antagonists
03/05/2014CN103619833A Novel compounds for organic electronic material and organic electroluminescent device using the same
03/05/2014CN103619817A Novel bicyclic nitrogen containing heteroaryl TGR5 receptor modulators
03/05/2014CN103619814A Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome
03/05/2014CN103613587A N,N-substituted 3-aminopyrrolidine compound capable of being used as monoamine reuptake inhibitor
03/05/2014CN103613527A N,N-substituted 3-aminopyrrolidine compound capable of being used as monoamine reuptake inhibitor
03/05/2014CN102498091B Glycine compound
03/05/2014CN102414199B Diaryl ethers
03/05/2014CN102264729B Novel polymorphic forms of 6-(1-methyl-1h-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-yl-ethoxy)-pyrimidin-2-yl]-benzyl}-2h-pyridazin-3-one dihydrogenphosphate and processes of manufacturing thereof
03/05/2014CN101704812B Azasugar compounds and preparation method and application thereof
03/05/2014CN101495464B Prokineticin 1 receptor antagonists
03/04/2014US8664407 Chemical linkers with single amino acids and conjugates thereof
03/04/2014US8664390 Process for the introduction of hydroxyethoxy side chain in bosentan
03/04/2014US8664219 Aminopyrimidines useful as inhibitors of protein kinases
03/04/2014US8663990 Measurement method utilizing internal standard substance
03/04/2014US8663901 Fluorine-free fused ring heteroaromatic photoacid generators and resist compositions containing the same
02/2014
02/27/2014WO2014031971A1 Herbicidal pyridazinones
02/27/2014WO2014031784A1 Compounds for the treatment of paramoxyvirus viral infections
02/27/2014WO2014031204A2 Carbohydrate-selective receptors
02/27/2014WO2014030743A1 Heterocycic compound
02/27/2014WO2014029193A1 Dihydropyrimidine compounds and their application in pharmaceuticals
02/27/2014WO2014029007A1 Protein kinase inhibitors
02/27/2014WO2013168927A3 Novel compound and organic electroluminescent device comprising same
02/27/2014US20140058047 Ionic Viscoelastics and Viscoelastic Salts
02/27/2014US20140057928 Solid state forms of a potent hcv inhibitor
02/27/2014US20140057927 Inhibitors of beta-secretase
02/27/2014US20140057915 Kinase inhibitors
02/27/2014US20140057913 Aurora kinase inhibitors and methods of making and using thereof
02/27/2014US20140057912 Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
02/27/2014US20140057911 Novel 4,6-disubstituted aminopyrimidine derivatives having both aromatic and halogenic substituents
02/27/2014US20140057906 Modulators of atp-binding cassette transporters
02/27/2014US20140057900 Pro-Neurogenic Compounds
02/27/2014US20140057890 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
02/27/2014US20140057889 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
02/27/2014US20140056880 Triazole compounds as ksp inhibitors
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 626